|
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T. and Kishimoto, T. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Embo J, 9, 1897-1906.
Allen, J.D., Brinkhuis, R.F., Wijnholds, J. and Schinkel, A.H. (1999) The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. Cancer Res, 59, 4237-4241.
Allikmets, R., Schriml, L.M., Hutchinson, A., Romano-Spica, V. and Dean, M. (1998) A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. Cancer Res, 58, 5337-5339.
Armstrong, S.A., Barry, D.A., Leggett, R.W. and Mueller, C.R. (1997) Casein kinase II-mediated phosphorylation of the C terminus of Sp1 decreases its DNA binding activity. J Biol Chem, 272, 13489-13495.
Borellini, F., Aquino, A., Josephs, S.F. and Glazer, R.I. (1990) Increased expression and DNA-binding activity of transcription factor Sp1 in doxorubicin-resistant HL-60 leukemia cells. Mol Cell Biol, 10, 5541-5547.
Borst, P., Evers, R., Kool, M. and Wijnholds, J. (2000) A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst, 92, 1295-1302.
Bouwman, P. and Philipsen, S. (2002) Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol, 195, 27-38.
Cao, Z., Umek, R.M. and McKnight, S.L. (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev, 5, 1538-1552.
Chang, C.J., Chen, T.T., Lei, H.Y., Chen, D.S. and Lee, S.C. (1990) Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Mol Cell Biol, 10, 6642-6653.
Chen, B.K., Kung, H.C., Tsai, T.Y. and Chang, W.C. (2000) Essential role of mitogen-activated protein kinase pathway and c-Jun induction in epidermal growth factor-induced gene expression of human 12-lipoxygenase. Mol Pharmacol, 57, 153-161.
Chun, R.F., Semmes, O.J., Neuveut, C. and Jeang, K.T. (1998) Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J Virol, 72, 2615-2629.
Cole, S.P., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M. and Deeley, R.G. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
Colgan, J. and Manley, J.L. (1995) Cooperation between core promoter elements influences transcriptional activity in vivo. Proc Natl Acad Sci U S A, 92, 1955-1959.
Courey, A.J., Holtzman, D.A., Jackson, S.P. and Tjian, R. (1989) Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell, 59, 827-836.
Datta, P.K., Raychaudhuri, P. and Bagchi, S. (1995) Association of p107 with Sp1: genetically separable regions of p107 are involved in regulation of E2F- and Sp1-dependent transcription. Mol Cell Biol, 15, 5444-5452.
Dean, M. and Allikmets, R. (2001) Complete characterization of the human ABC gene family. J Bioenerg Biomembr, 33, 475-479.
Dennig, J., Beato, M. and Suske, G. (1996) An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. Embo J, 15, 5659-5667.
Descombes, P., Chojkier, M., Lichtsteiner, S., Falvey, E. and Schibler, U. (1990) LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes Dev, 4, 1541-1551.
Descombes, P. and Schibler, U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell, 67, 569-579.
Ding, H., Benotmane, A.M., Suske, G., Collen, D. and Belayew, A. (1999) Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene. J Biol Chem, 274, 19573-19580.
Doyle, L.A., Yang, W., Abruzzo, L.V., Krogmann, T., Gao, Y., Rishi, A.K. and Ross, D.D. (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A, 95, 15665-15670.
Dynan, W.S. and Tjian, R. (1983a) Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell, 32, 669-680.
Dynan, W.S. and Tjian, R. (1983b) The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell, 35, 79-87.
Emili, A., Greenblatt, J. and Ingles, C.J. (1994) Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol, 14, 1582-1593.
Fojas de Borja, P., Collins, N.K., Du, P., Azizkhan-Clifford, J. and Mudryj, M. (2001) Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. Embo J, 20, 5737-5747.
Hagen, G., Dennig, J., Preiss, A., Beato, M. and Suske, G. (1995) Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. J Biol Chem, 270, 24989-24994.
Hagen, G., Muller, S., Beato, M. and Suske, G. (1992) Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res, 20, 5519-5525.
Hagen, G., Muller, S., Beato, M. and Suske, G. (1994) Sp1-mediated transcriptional activation is repressed by Sp3. Embo J, 13, 3843-3851.
Haidweger, E., Novy, M. and Rotheneder, H. (2001) Modulation of Sp1 activity by a cyclin A/CDK complex. J Mol Biol, 306, 201-212.
Harrison, S.M., Houzelstein, D., Dunwoodie, S.L. and Beddington, R.S. (2000) Sp5, a new member of the Sp1 family, is dynamically expressed during development and genetically interacts with Brachyury. Dev Biol, 227, 358-372.
Hata, Y., Duh, E., Zhang, K., Robinson, G.S. and Aiello, L.P. (1998) Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem, 273, 19294-19303.
Hendricks-Taylor, L.R. and Darlington, G.J. (1995) Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res, 23, 4726-4733.
Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T. and Sugiyama, Y. (1998) Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol, 53, 1068-1075.
Hirohashi, T., Suzuki, H. and Sugiyama, Y. (1999) Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). J Biol Chem, 274, 15181-15185.
Hoey, T., Weinzierl, R.O., Gill, G., Chen, J.L., Dynlacht, B.D. and Tjian, R. (1993) Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell, 72, 247-260.
Hopper, E., Belinsky, M.G., Zeng, H., Tosolini, A., Testa, J.R. and Kruh, G.D. (2001) Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily. Cancer Lett, 162, 181-191.
Hurst, H.C. (1995) Transcription factors 1: bZIP proteins. Protein Profile, 2, 101-168.
Ishikawa, T. (1992) The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci, 17, 463-468.
Jackson, S., Gottlieb, T. and Hartley, K. (1993) Phosphorylation of transcription factor Sp1 by the DNA-dependent protein kinase. Adv Second Messenger Phosphoprotein Res, 28, 279-286.
Jackson, S.P., MacDonald, J.J., Lees-Miller, S. and Tjian, R. (1990) GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell, 63, 155-165.
Jackson, S.P. and Tjian, R. (1988) O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation. Cell, 55, 125-133.
Jedlitschky, G., Burchell, B. and Keppler, D. (2000) The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem, 275, 30069-30074.
Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G. and Keppler, D. (1996) Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res, 56, 988-994.
Johnson, P.F. and McKnight, S.L. (1989) Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem, 58, 799-839.
Juliano, R.L. and Ling, V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta, 455, 152-162.
Kadonaga, J.T., Carner, K.R., Masiarz, F.R. and Tjian, R. (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 51, 1079-1090.
Kadonaga, J.T., Courey, A.J., Ladika, J. and Tjian, R. (1988) Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science, 242, 1566-1570.
Karlseder, J., Rotheneder, H. and Wintersberger, E. (1996) Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol, 16, 1659-1667.
Kingsley, C. and Winoto, A. (1992) Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression. Mol Cell Biol, 12, 4251-4261.
Kool, M., de Haas, M., Scheffer, G.L., Scheper, R.J., van Eijk, M.J., Juijn, J.A., Baas, F. and Borst, P. (1997) Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res, 57, 3537-3547.
Kool, M., van der Linden, M., de Haas, M., Scheffer, G.L., de Vree, J.M., Smith, A.J., Jansen, G., Peters, G.J., Ponne, N., Scheper, R.J., Elferink, R.P., Baas, F. and Borst, P. (1999) MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A, 96, 6914-6919.
Kruh, G.D., Zeng, H., Rea, P.A., Liu, G., Chen, Z.S., Lee, K. and Belinsky, M.G. (2001) MRP subfamily transporters and resistance to anticancer agents. J Bioenerg Biomembr, 33, 493-501.
Landschulz, W.H., Johnson, P.F., Adashi, E.Y., Graves, B.J. and McKnight, S.L. (1988) Isolation of a recombinant copy of the gene encoding C/EBP. Genes Dev, 2, 786-800.
Landschulz, W.H., Johnson, P.F. and McKnight, S.L. (1989) The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science, 243, 1681-1688.
Lee, J.S., Galvin, K.M. and Shi, Y. (1993) Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci U S A, 90, 6145-6149.
Lekstrom-Himes, J. and Xanthopoulos, K.G. (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem, 273, 28545-28548.
Lekstrom-Himes, J.A. (2001) The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation. Stem Cells, 19, 125-133.
Li, B., Adams, C.C. and Workman, J.L. (1994) Nucleosome binding by the constitutive transcription factor Sp1. J Biol Chem, 269, 7756-7763.
Lin, F.T., MacDougald, O.A., Diehl, A.M. and Lane, M.D. (1993) A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc Natl Acad Sci U S A, 90, 9606-9610.
Lin, S.Y., Black, A.R., Kostic, D., Pajovic, S., Hoover, C.N. and Azizkhan, J.C. (1996) Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol, 16, 1668-1675.
Madon, J., Hagenbuch, B., Landmann, L., Meier, P.J. and Stieger, B. (2000) Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol, 57, 634-641.
Marin, M., Karis, A., Visser, P., Grosveld, F. and Philipsen, S. (1997) Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation. Cell, 89, 619-628.
Mastrangelo, I.A., Courey, A.J., Wall, J.S., Jackson, S.P. and Hough, P.V. (1991) DNA looping and Sp1 multimer links: a mechanism for transcriptional synergism and enhancement. Proc Natl Acad Sci U S A, 88, 5670-5674.
Matsushita, K. and Sugiura, Y. (2001) Effect of arginine mutation of alanine-556 on DNA recognition of zinc finger protein Sp1. Bioorg Med Chem, 9, 2259-2267.
Milanini-Mongiat, J., Pouyssegur, J. and Pages, G. (2002) Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem, 277, 20631-20639.
Miyake, K., Mickley, L., Litman, T., Zhan, Z., Robey, R., Cristensen, B., Brangi, M., Greenberger, L., Dean, M., Fojo, T. and Bates, S.E. (1999) Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. Cancer Res, 59, 8-13.
Mortensen, E.R., Marks, P.A., Shiotani, A. and Merchant, J.L. (1997) Epidermal growth factor and okadaic acid stimulate Sp1 proteolysis. J Biol Chem, 272, 16540-16547.
Murata, Y., Kim, H.G., Rogers, K.T., Udvadia, A.J. and Horowitz, J.M. (1994) Negative regulation of Sp1 trans-activation is correlated with the binding of cellular proteins to the amino terminus of the Sp1 trans-activation domain. J Biol Chem, 269, 20674-20681.
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J.M., Behringer, R.R. and de Crombrugghe, B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell, 108, 17-29.
Ossipow, V., Descombes, P. and Schibler, U. (1993) CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci U S A, 90, 8219-8223.
Pal, S., Claffey, K.P., Cohen, H.T. and Mukhopadhyay, D. (1998) Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta. J Biol Chem, 273, 26277-26280.
Pascal, E. and Tjian, R. (1991) Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev, 5, 1646-1656.
Poli, V. (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem, 273, 29279-29282.
Poli, V., Mancini, F.P. and Cortese, R. (1990) IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell, 63, 643-653.
Rafty, L.A. and Khachigian, L.M. (2001) Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta. Nucleic Acids Res, 29, 1027-1033.
Ramji, D.P. and Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J, 365, 561-575.
Ray, A. and Ray, B.K. (1994) Serum amyloid A gene expression under acute-phase conditions involves participation of inducible C/EBP-beta and C/EBP-delta and their activation by phosphorylation. Mol Cell Biol, 14, 4324-4332.
Roberts, M.S., Magnusson, B.M., Burczynski, F.J. and Weiss, M. (2002) Enterohepatic circulation: physiological, pharmacokinetic and clinical implications. Clin Pharmacokinet, 41, 751-790.
Roeder, R.G. (1991) The complexities of eukaryotic transcription initiation: regulation of preinitiation complex assembly. Trends Biochem Sci, 16, 402-408.
Rohlff, C., Ahmad, S., Borellini, F., Lei, J. and Glazer, R.I. (1997) Modulation of transcription factor Sp1 by cAMP-dependent protein kinase. J Biol Chem, 272, 21137-21141.
Roman, C., Platero, J.S., Shuman, J. and Calame, K. (1990) Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev, 4, 1404-1415.
Ron, D. and Habener, J.F. (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev, 6, 439-453.
Roos, M.D., Su, K., Baker, J.R. and Kudlow, J.E. (1997) O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol Cell Biol, 17, 6472-6480.
Ryu, S., Zhou, S., Ladurner, A.G. and Tjian, R. (1999) The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature, 397, 446-450.
Scheffer, G.L., Kool, M., de Haas, M., de Vree, J.M., Pijnenborg, A.C., Bosman, D.K., Elferink, R.P., van der Valk, P., Borst, P. and Scheper, R.J. (2002) Tissue distribution and induction of human multidrug resistant protein 3. Lab Invest, 82, 193-201.
Scohy, S., Gabant, P., Van Reeth, T., Hertveldt, V., Dreze, P.L., Van Vooren, P., Riviere, M., Szpirer, J. and Szpirer, C. (2000) Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family. Genomics, 70, 93-101.
Screpanti, I., Romani, L., Musiani, P., Modesti, A., Fattori, E., Lazzaro, D., Sellitto, C., Scarpa, S., Bellavia, D., Lattanzio, G. and et al. (1995) Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. Embo J, 14, 1932-1941.
Seto, E., Lewis, B. and Shenk, T. (1993) Interaction between transcription factors Sp1 and YY1. Nature, 365, 462-464.
Staudinger, J.L., Madan, A., Carol, K.M. and Parkinson, A. (2003) Regulation of drug transporter gene expression by nuclear receptors. Drug Metab Dispos, 31, 523-527.
Sterneck, E., Paylor, R., Jackson-Lewis, V., Libbey, M., Przedborski, S., Tessarollo, L., Crawley, J.N. and Johnson, P.F. (1998) Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A, 95, 10908-10913.
Su, K., Roos, M.D., Yang, X., Han, I., Paterson, A.J. and Kudlow, J.E. (1999) An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. J Biol Chem, 274, 15194-15202.
Su, K., Yang, X., Roos, M.D., Paterson, A.J. and Kudlow, J.E. (2000) Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem J, 348 Pt 2, 281-289.
Su, W., Jackson, S., Tjian, R. and Echols, H. (1991) DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev, 5, 820-826.
Suske, G. (1999) The Sp-family of transcription factors. Gene, 238, 291-300.
Takada, T., Suzuki, H. and Sugiyama, Y. (2000) Characterization of 5''-flanking region of human MRP3. Biochem Biophys Res Commun, 270, 728-732.
Tanaka, T., Yoshida, N., Kishimoto, T. and Akira, S. (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. Embo J, 16, 7432-7443.
Tanese, N., Saluja, D., Vassallo, M.F., Chen, J.L. and Admon, A. (1996) Molecular cloning and analysis of two subunits of the human TFIID complex: hTAFII130 and hTAFII100. Proc Natl Acad Sci U S A, 93, 13611-13616.
Tjian, R. and Maniatis, T. (1994) Transcriptional activation: a complex puzzle with few easy pieces. Cell, 77, 5-8.
Tzeng, S.J. and Huang, J.D. (2002) Transcriptional regulation of the rat Mrp3 promoter in intestine cells. Biochem Biophys Res Commun, 291, 270-277.
Van Aubel, R.A., Masereeuw, R. and Russel, F.G. (2000) Molecular pharmacology of renal organic anion transporters. Am J Physiol Renal Physiol, 279, F216-232.
Vasseur-Cognet, M. and Lane, M.D. (1993) Trans-acting factors involved in adipogenic differentiation. Curr Opin Genet Dev, 3, 238-245.
Vinson, C.R., Sigler, P.B. and McKnight, S.L. (1989) Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science, 246, 911-916.
Wijnholds, J., Mol, C.A., van Deemter, L., de Haas, M., Scheffer, G.L., Baas, F., Beijnen, J.H., Scheper, R.J., Hatse, S., De Clercq, E., Balzarini, J. and Borst, P. (2000) Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A, 97, 7476-7481.
Williams, S.C., Cantwell, C.A. and Johnson, P.F. (1991) A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev, 5, 1553-1567.
Yamanaka, R., Kim, G.D., Radomska, H.S., Lekstrom-Himes, J., Smith, L.T., Antonson, P., Tenen, D.G. and Xanthopoulos, K.G. (1997) CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci U S A, 94, 6462-6467.
Yang, X., Su, K., Roos, M.D., Chang, Q., Paterson, A.J. and Kudlow, J.E. (2001) O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A, 98, 6611-6616.
Yubero, P., Manchado, C., Cassard-Doulcier, A.M., Mampel, T., Vinas, O., Iglesias, R., Giralt, M. and Villarroya, F. (1994) CCAAT/enhancer binding proteins alpha and beta are transcriptional activators of the brown fat uncoupling protein gene promoter. Biochem Biophys Res Commun, 198, 653-659.
Yukawa, K., Tanaka, T., Tsuji, S. and Akira, S. (1998) Expressions of CCAAT/Enhancer-binding proteins beta and delta and their activities are intensified by cAMP signaling as well as Ca2+/calmodulin kinases activation in hippocampal neurons. J Biol Chem, 273, 31345-31351.
Zeng, H., Bain, L.J., Belinsky, M.G. and Kruh, G.D. (1999) Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Res, 59, 5964-5967.
Zeng, H., Liu, G., Rea, P.A. and Kruh, G.D. (2000) Transport of amphipathic anions by human multidrug resistance protein 3. Cancer Res, 60, 4779-4784.
Zheng, X.L., Matsubara, S., Diao, C., Hollenberg, M.D. and Wong, N.C. (2001) Epidermal growth factor induction of apolipoprotein A-I is mediated by the Ras-MAP kinase cascade and Sp1. J Biol Chem, 276, 13822-13829.
Zhu, Q. and Liao, K. (2000) Differential expression of the adipocyte amino acid transporter is transactivated by SP1 and SP3 during the 3T3-L1 preadipocyte differentiation process. Biochem Biophys Res Commun, 271, 100-106.
|